Summertime dosage-dependent hypersensitivity to an angiotensin II receptor blocker

BMC Research Notes

Volumn 8, Issue 1, 2015, Pages

  Forsdyke, Donald R ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Acute kidney injury; Angiotensin II receptor; Environmental temperature; Hypotension; J curve; Losartan

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; LOSARTAN;

BLOOD PRESSURE; CASE REPORT; CHEMICALLY INDUCED; DOSE CALCULATION; DOSE RESPONSE; DRUG EFFECTS; HUMAN; HYPERTENSION; HYPOTENSION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; SEASON; TEMPERATURE; TIME FACTOR;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DOSAGE CALCULATIONS; HUMANS; HYPERTENSION; HYPOTENSION; LOSARTAN; MALE; MIDDLE AGED; SEASONS; TEMPERATURE; TIME FACTORS;

EID: 85018145949     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/s13104-015-1215-8     Document Type: Article

References (49)

1. Charach G, Rabinovich PD, Weintraub M (2004) Seasonal changes in blood pressure and frequency of related complications in elderly Israeli patients with essential hypertension. Gerontol 50:315-321
2. Fedecostante M, Barbatelli P, Guerra F, Espinosa E, Dessl-Fulgheri P, Sarzani R (2012) Summer does not always mean lower: seasonality of 24 h, daytime, and night-time blood pressure. J Hypertens 30:1392-1398
3. Modesti PA, Morabito M, Bertolozzi I, Massetti L, Panci G, Lumachi C et al (2006) Weather-related changes in 24-h blood pressure profile: effects of age and implications for hypertension management. Hypertension 47:155-161
4. Lewington S, Li L, Sherliker P, Guo Y, Millwood I, Bian Z et al (2012) Seasonal variation in blood pressure and its relationship with outdoor temperature in 10 diverse regions of China: the China Kadoorie Biobank. J Hypertens 30:1383-1391
5. Modesti PA (2013) Season, temperature and blood pressure: a complex interaction. Eur J Int Med 24:604-607
6. Hozawa A, Kuriyama S, Shimazu T, Ohmori-Matsuda K, Tsuji I (2011) Seasonal variation in home blood pressure measurements and relation to outside temperature in Japan. Clin Exp Hypertens 33:153-158
7. Aubinière-Robb L, Jeemon P, Hastie CE, Patel RK, McCallum L, Morrison LD et al (2013) Blood pressure response to patterns of weather fluctuations and effect on mortality. Hypertension 62:190-196
8. Tu Y-K, Chien K-L, Chiu Y-W, Ellison GTH (2013) Seasonal variation in blood pressure is modulated by gender and age but not by BMI in a large Taiwanese population, 1996-2006. J Am Soc Hypertens 7:216-228
9. Floras JS (2013) Blood pressure variability: a novel and important risk factor. Can J Cardiol 29:557-563
10. Messerli FH, Williams B, Ritz E (2007) Essential hypertension. Lancet 370:591-603
11. Modesti PA, Morabito M, Massetti L, Rapi S, Orlandini S, Mancia G et al (2013) Seasonal blood pressure changes. An independent relationship with temperature and daylight hours. Hypertension 61:908-914
12. Cuspidi C, Ochoa JE, Parati G (2012) Seasonal variations in blood pressure: a complex phenomenon. J Hypertens 30:1315-1320
13. Tomlinson LA, Abel GA, Chaudhry AN, Tomson CR, Wilkinson IB, Roland MO et al (2013) ACE inhibitor and angiotensin-II receptor antagonist prescribing and hospital admissions with acute kidney injury: a longitudinal ecological study. PLoS One 8:e78465
14. Handler J (2011) Seasonal variability of blood pressure in California. J Clin Hypert 50:856-860
15. Chen Q, Wang J, Tian J, Tang X, Yu C, Marshall RJ et al (2013) Association between ambient temperature and blood pressure and blood pressure regulators: 1831 hypertensive patients followed up for 3 years. PLoS One 8(12):e84522
16. Mancia G, Grassi G (2014) Aggressive blood pressure lowering is dangerous: the J-curve: pro side of the argument. Hypertension 63:29-36
17. Forsdyke DR (2013) Seasonal dosage-dependent hypersensitivity to the angiotensin II receptor blocker, losartan: a case report and review. PeerJ PrePrints 1:e144v1
18. Siderovski DP, Heximer SP, Forsdyke DR (1994) A human gene encoding a putative basic helix-loop-helix phosphoprotein whose messenger-RNA increases rapidly in cycloheximide-treated blood mononuclear cells. DNA Cell Biol 13:125-147
19. Tang M, Wang G, Lu P, Karas RH, Aronovitz M, Heximer SP et al (2003) Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat Med 9:1506-1512
20. Calò LA, Pagnin E, Davis PA, Sartori M, Ceolotto G, Pessina AC et al (2004) Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's syndrome. A role in the control of vascular tone and implication for hypertension. J Clin Endocrinol Metab 89:4153-4157
21. Tracey KJ (2014) Hypertension: an immune disorder? Immunity 41:673-674
22. Schutte R, Thijs L, Liu Y-P, Asayama K, Jin Y, Odili A et al (2012) Within-subject blood pressure level, not variability, predicts fatal and nonfatal outcomes in a general population. Hypertension 60:1138-1147
23. Christen Y, Waeber B, Nussberger J, Porchet M, Borland RM, Lee RJ et al (1991) Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II. Circulation 83:1333-1342
24. Gottlieb SS, Dickstein K, Fleck E, Kostis J, Levine TB, LeJemtel T et al (1993) Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure. Circulation 88:1602-1609
25. Wong PC, Barnes TB, Chiu AT, Christ DD, Duncia JV, Herblin WF et al (1991) Losartan (DuP 753), an orally active nonpeptide angiotensin II receptor antagonist. Cardiovasc Drug Rev 9:317-339
26. Schwartz BG, Kloner RA (2012) Seasonal variation in cardiac death rates is uniform across different climates. Circulation 126:A11723
27. Munafo A, Christen Y, Nussberger J, Shum LY, Borland RM, Lee RJ et al (1992) Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist. Clin Pharmacol Ther 51:513-521
28. Lo M-W, Goldberg MR, McCrea JB, Lu H, Furtek CI, Bjornsson TD (1995) Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3 174 in humans. Clin Pharmacol Ther 58:641-649
29. Matsubara H (1998) Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 83:1182-1191
30. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T (2000) International Union of Pharmacology. XXIII. The Angiotensin II Receptors. Pharm Rev 52:415-472
31. Cosentino F, Savoia C, De Paolis P, Francia P, Russo A, Maffei A et al (2005) Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists. Am J Hypertens 18:493-499
32. Savoia C, Tabet F, Yao G, Schiffrin EL, Touyz RM (2005) Negative regulation of Rho/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation. J Hypertens 23:1037-1045
33. Li XC, Widdop RE (2004) AT2 receptor-mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR. Brit J Pharm 142:821-830
34. 2 receptor. Curr Hypertens Rep 15:25-30
35. Schalekamp MADH, Danser AHJ (2013) How does the angiotensin II type 1 receptor 'trump'the type 2 receptor in blood pressure control? J Hypertens 31:705-712
36. Abdulla MH, Johns EJ (2013) Role of angiotensin AT2 receptors and nitric oxide in the cardiopulmonary baroreflex control of renal sympathetic nerve activity in rats. J Hypertens 31:1837-1846
37. Kristal-Boneh E, Froom P, Harari G, Shapiro Y, Green MS (1993) Seasonal changes in red blood cell parameters. Br J Haematol 85:603-607
38. Calò L, Davis PA, Rossi GP (2014) Understanding the mechanisms of angiotensin II signaling involved in hypertension and its long-term sequelae: insights from Bartter's and Gitelman's syndromes, human models of endogenous angiotensin II signaling antagonism. J Hypert 32:2109-2119
39. Maiolino G, Naso E, Calò LA (2014) Angiotensin II type 2 receptor effects: lesson from a human model of vascular hyporeactivity. Letter regarding Kemp et al. Circ Res 115:e24-e25
40. Rice ASC, Dworkin RH, McCarthy TD, Anand P, Bountra C, McCloud PI et al (2014) EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial. Lancet 383:1637-1647
41. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J et al (2014) 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311:507-520
42. Paratia G, Bilo G (2010) Evening administration of antihypertensive drugs: filling a knowledge gap. J Hypertens 28:1390-1392
43. Fuchs FD, Fuchs SC (2014) Blood pressure targets in the treatment of high blood pressure: a reappraisal of the J-shaped phenomenon. J Hum Hypertens 28:80-84
44. Konstam MA, Neaton JD, Dickstein K, Drexler H, Komajda M, Martinez FA et al (2009) Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial. Lancet 374:1840-1848
45. Gasparrini A, Guo Y, Hashizume M, Lavigne E, Zanobetti A, Schwartz J et al (2015) Mortality risk attributable to high and low ambient temperature: a multicountry observational study. Lancet. doi: 10.1016/S0140-6736(14)62114-0
46. Elgendy IY, Huo T, Chik V, Pepine CJ, Bavry AA (2015) Efficacy and safety of angiotensin receptor blockers in older patients: a meta-analysis of randomized trials. Am J Hypert 28:576-585
47. Palmer SC, Mavridis D, Navarese E, Craig JC, Tonelli M, Salanti G et al (2015) Comparative efficiency and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis. Lancet 385:2047-2056
48. Sanayan B, Westendorp RGJ (2015) Blood pressure control and cognitive impairment - why low is not always better. JAMA Int Med 175:586-587
49. Verberk WJ, Kroon AA, Lenders JWM, Kessels AGH, van Montfrans GA, Smit AJ et al (2007) Self-measurement of blood pressure at home reduces the need for antihypertensive drugs. A randomized, controlled trial. Hypertension 50:1019-1025